The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
Wednesday, August 12, 2020
Precigen ActoBio has met the primary endpoint assessing safety and tolerability in the monotherapy portion of the ongoing study investigating AG019 ...
read more
Wednesday, August 12, 2020
Enlivex announced the first patient has been dosed in an investigator-initiated multi-center clinical trial of AllocetraTM in COVID-19 patients with ...
read more
PTx anounced a $35 million milestone-based OTA with the DOD to fund two clinical studies of inhaled Leukine in patients with COVID-19 associated acute...
read more
Elios announced final data from a prospective clinical trial evaluating adjuvant use of its personalized TLPLDC vaccine in patients with Stage III or ...
read more
NeuroRx has been granted IND permission to test RLF-100 for inhaled use in patients with moderate and severe COVID-19 in order to prevent progression ...
read more
Orion Biotechnology Canada has received advisory services and conditional funding from the NRC IRAP to support OB-002, a potential treatment for SARS-...
read more
Fortress Biotech announced the EMA Committee for Orphan Medicinal Products issued a positive opinion on Cyprium Therapeutics’ application for Orphan ...
read more
Members of the COVID R&D Alliance announced the first patients enrolled in the I-SPY COVID Trial.
read more
NeuroRx and Relief Therapeutics announced that RLF-100 (aviptadil) showed rapid recovery from respiratory failure in the most critically ill patients ...
read more
The FDA has approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with tuberous sclerosis complex.
read more
Kadimastem announced its lead product, AstroRx®, showed a positive efficacy signal and a good safety profile in Cohort B of the Company's Phase 1/2a ...
read more
Janssen Research & Development
Janssen announced the FDA has approved the sNDA for SPRAVATO CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in ...
read more
Neutrolis announced the development of NTR-441, a DNASE1L3 enzyme analog that has the potential to rapidly and systemically clear NETs for COVID-19.
read more
Thursday, August 06, 2020
BioAegis Therapeutics enrolled its first patient in its Phase 2 study of hospitalized patients with severe COVID-19 pneumonia.
read more
Thursday, August 06, 2020
Johnson & Johnson has entered into an agreement with the U.S. government for the large scale domestic manufacturing and delivery in the U.S. of 100 ...
read more